Xianghua Luo, PhD

My research interests are in the development and application of methods for recurrent event data, survival data, and longitudinal data, as well as the design and analysis of clinical trials. My collaborations include cancer research, blood and marrow transplant, tobacco use and smoking cessation, and health disparity research. 

• Member, Delta Omega Honorary Society in Public Health

• 2013-2018, NIH/NCI, "Chemoprevention of inflammation-driven lung cancer", Co-Investigator
• 2014-2019, NIH/NCI, "Cancer Center Support Grant", Co-Investigator
• 2014-2019, NIH/NHLBI, "Enhancing Smoking Cessation in Homeless Populations", Co-Investigator
• 2014-2019, NIH, "Preclinical evaluation and clinical translation of novel bispecific toxins that target sarcoma tumors and their vasculature", Statistician Mentor
• 2015-2022, NIH/NCI, "Viral priming and targeting NK cells against solid tumor malignancies", Co-Investigator
• 2015–2020, NIH/NIC, "Biology and Transplantation of the Hematopoietic Stem Cell," Co-Investigator
• 2016–2021, NIH/NCI, "NK Cells, Their Receptors, Transplantation and Cancer Therapy," Co-Investigator
• 2016-2019, DOD, "Enhancing Natural Killer Cell Mediated Targeting And Responses To Myeloid Leukemias", Statistician
• 2017-2022, FDA/NIDA, Evaluating New Nicotine Standards for Cigarettes", Co-Investigator

See a full list of publications on Google Scholar